Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind study of Dysport for pediatric upper limb spasticity
MOH_2017-05-09_000401Phase 3Completed
- Sponsor
- Ipsen Innovation
- Start
- Jan 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in upper extremity spasticity and cerebral palsy (CP) (4 arms), sponsored by Ipsen Innovation. Started Jan 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
upper extremity spasticitycerebral palsy (CP)
Beyond the preview
Go deeper on MOH_2017-05-09_000401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-05-09_000401.